Akso Health (AHG) Invested Capital (2017 - 2025)

Akso Health has reported Invested Capital for 9 years, with the latest figure at $200.3 million in Q3 2025.

• For the quarter ending Q3 2025, Invested Capital fell 1.16% year-over-year to $200.3 million; the trailing twelve-month figure through Sep 2025 stood at $200.3 million (down 1.16% YoY), and the FY2025 full-year result was $201.2 million, up 43.25% from the prior year.
• Invested Capital for Q3 2025 stood at $200.3 million, roughly flat from $201.2 million in the prior quarter.
• The five-year high for Invested Capital was $2000.0 billion in Q3 2021, with the low at $15.0 million in Q3 2023.
• Historically, Invested Capital has averaged $200.1 billion across 5 years, with a median of $95.0 million in 2022.
• Annual changes were most pronounced in 2021 — Invested Capital jumped 74134957.02% — and 2022, when it slumped 100.0%.
• Akso Health's Invested Capital stood at $2000.0 billion in 2021, then tumbled by 100.0% to $19.6 million in 2022, then declined by 23.44% to $15.0 million in 2023, then jumped by 1249.43% to $202.7 million in 2024, then decreased by 1.16% to $200.3 million in 2025.
• The last three Invested Capital figures came in at $200.3 million (Q3 2025), $201.2 million (Q1 2025), and $202.7 million (Q3 2024), per Business Quant data.